EcoDrugPlus


Trade Names	INTRALIPID 10% INTRALIPID 20% INTRALIPID 30% LIPOSYN III 10% LIPOSYN III 20% LIPOSYN III 30% NUTRILIPID 10% NUTRILIPID 20% SOYACAL 10% SOYACAL 20% TRAVAMULSION 10% TRAVAMULSION 20%
Synonyms	Glycine max seed oil Intralipid Intralipid (fresenius) Liposyn (hospira) Liposyn Iii Nutrilipid Nutrilipid (b braun) Soyacal Soybean oil Soybean oil, refined Travamulsion
Status
Molecule Category	Free-form
UNII	241ATL177A

Trade Names

INTRALIPID 10%

INTRALIPID 20%

INTRALIPID 30%

LIPOSYN III 10%

LIPOSYN III 20%

LIPOSYN III 30%

NUTRILIPID 10%

NUTRILIPID 20%

SOYACAL 10%

SOYACAL 20%

TRAVAMULSION 10%

TRAVAMULSION 20%

Synonyms

Glycine max seed oil

Intralipid

Intralipid (fresenius)

Liposyn (hospira)

Liposyn Iii

Nutrilipid

Nutrilipid (b braun)

Soyacal

Soybean oil

Soybean oil, refined

Travamulsion

Status

Molecule Category

Free-form

UNII

241ATL177A


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Resources	Reference
ChEMBL	CHEMBL1201485
FDA SRS	241ATL177A

Resources

Reference

ChEMBL

CHEMBL1201485

FDA SRS

241ATL177A


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

SOYBEAN OIL

Cross References